Formulary Search
Search Results : Hypertension (Diltiazem hydrochloride - Hypertension)
Records returned : 53 (on 14 Mar 2026 at 08:13:39).
Return to search results for ' Hypertension '.
Show Icon and Status Keys
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Prescribe by BRAND
Tildiem Retard (TWICE daily) are the lowest cost brand in Primary Care for patients requiring a tablet formulation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release capsules
Restrictions / Comments:
Important
Prescribe by BRAND
Angitil SR capsules (TWICE daily) or Zemtard XL or Slozem (ONCE daily) are the lowest cost brands for Primary Care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Preferred
Step 4 of the hypertension pathway. Bisoprolol / atenolol are the preferred, cardio-selective beta blockers for hypertension.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Step 4 of the hypertension pathway. Bisoprolol / atenolol are the preferred, cardio-selective beta blockers for hypertension.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Preferred angiotensin II receptor blocker
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Immediate release tablets
Restrictions / Comments:
Important
Step 4 of the hypertension pathway.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Step 4 of the hypertension pathway.
Use immediate release tablets
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Immediate release tablets
Restrictions / Comments:
Important
Preferred
Preferred thiazide diuretic
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Modified-release indpapmide tablets are not a preferred treatment option. Immediate-release tablets are recommended.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Use an ARB where possible. If an ACEi is required (patient with heart failure or post MI), ramipril is the preferred option.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Use an ARB where possible. If an ACEi is required (patient with heart failure or post MI), ramipril is the preferred option.
Liquid is very expensive (>£200 for 150ml - Drug Tariff Sep 2024).
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Preferred angiotensin II receptor blocker
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
ASPH restrict use to cardiology only.
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Prescribe by BRAND
Nifedipine once-daily tablets : there are limited options available on the market following the discontinuation of Adalat LA, Adipine XL and Fortipine LA. Prescribers should consider a twice-daily nifedipine tablet or a once-daily capsule. Additional information is available here: Discontinuation of Nifedipine (Adipine XL) 30mg and 60mg modified-release tablets – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release capsules
Restrictions / Comments:
Important
Prescribe by BRAND
Coracten SR (Twice daily) and Coracten XL (once daily) are the preferred capsule brands.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Prescribe by BRAND
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Preferred
Use an ARB where possible. If an ACEi is required (patient with heart failure or post MI), ramipril is the preferred option.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Indapamide is the preferred diuretic treatment option. No requirement to switch from bendroflumethiazide in stable patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not 1st line
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Step 4 of the hypertension pathway. Bisoprolol / atenolol are the preferred, cardio-selective beta blockers for hypertension.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred ACE inhibitor during breastfeeding (where an ACE inhibitor is appropriate)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
This is not a preferred treatment option but existing, stable patients may remain on treatment.
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
MHRA alert: Hydrochlorothiazide risk of non-melanoma skin cancer
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
MHRA alert: Hydrochlorothiazide risk of non-melanoma skin cancer
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
MHRA alert: Hydrochlorothiazide risk of non-melanoma skin cancer
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Step 4 of the hypertension pathway. Bisoprolol / atenolol are the preferred, cardio-selective beta blockers for hypertension.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Step 4 of the hypertension pathway. Bisoprolol / atenolol are the preferred, cardio-selective beta blockers for hypertension.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
2mg, 4mg and 8mg tablets
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Only the 500mcg tablets are licensed in the UK. 2mg and 5mg tablets as special order or import only (much more expensive)
Links :
Indication :
Status :
Formulations :
- Modified release capsules
- Oral solution
- Tablets
Restrictions / Comments:
Important
Not a preferred beta blocker for hypertension. The cardio-selective betablockers, bisoprolol or atenolol are the preferred options
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Step 4 of the hypertension pathway. Adjunct in resistant hypertension
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
MHRA alert: Hydrochlorothiazide risk of non-melanoma skin cancer
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Reserved for severe / resistant hypertension.
Initiation and stabilisation by the specialist before transfer of prescribing to GP.
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Prescribing in primary care on specialist recommendation only.
Reserved for severe / resistant hypertension.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Important
Hypertensive emergency (including pregnancy) or hypertension with renal complications
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Specialist only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
For use in patients who are unable to have oral spironolactone.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHS England guidance DO NOT ROUTINELY PRESCRIBE
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not for initiation in new patients. Existing patients may remain on therapy.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not for initiation in new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
The licensed (Xaqua) and unlicensed (Zaroxolyn) tablets have different bioavailabilities. These products are not interchangable=Prescribe by Brand
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHS England guidance DO NOT ROUTINELY PRESCRIBE
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Device
Restrictions / Comments:
Important
This device has not been agreed for inclusion on the formulary. Primary Care must not be asked to prescribe until a place in therapy has been agreed by the APC. Contact your pharmacy / medicines optimisation team for advice.
Formulary Status :
Links :